Procedural Complications, Rehospitalizations, and Repeat Procedures After Catheter Ablation for Atrial Fibrillation

The purpose of this study was to estimate rates and identify predictors of inpatient complications and 30-day readmissions, as well as repeat hospitalization rates for arrhythmia recurrence following atrial fibrillation (AF) ablation. AF is the most common clinically significant arrhythmia and is as...

Full description

Saved in:
Bibliographic Details
Published inJournal of the American College of Cardiology Vol. 59; no. 2; pp. 143 - 149
Main Authors Shah, Rashmee U., Freeman, James V., Shilane, David, Wang, Paul J., Go, Alan S., Hlatky, Mark A.
Format Journal Article
LanguageEnglish
Published New York, NY Elsevier Inc 10.01.2012
Elsevier
Elsevier Limited
Subjects
Online AccessGet full text
ISSN0735-1097
1558-3597
1558-3597
DOI10.1016/j.jacc.2011.08.068

Cover

Abstract The purpose of this study was to estimate rates and identify predictors of inpatient complications and 30-day readmissions, as well as repeat hospitalization rates for arrhythmia recurrence following atrial fibrillation (AF) ablation. AF is the most common clinically significant arrhythmia and is associated with increased morbidity and mortality. Radiofrequency or cryotherapy ablation of AF is a relatively new treatment option, and data on post-procedural outcomes in large general populations are limited. Using data from the California State Inpatient Database, we identified all adult patients who underwent their first AF ablation from 2005 to 2008. We used multivariable logistic regression to identify predictors of complications and/or 30-day readmissions and Kaplan-Meier analyses to estimate rates of all-cause and arrhythmia readmissions. Among 4,156 patients who underwent an initial AF ablation, 5% had periprocedural complications, most commonly vascular, and 9% were readmitted within 30 days. Older age, female, prior AF hospitalizations, and less hospital experience with AF ablation were associated with higher adjusted risk of complications and/or 30-day readmissions. The rate of all-cause hospitalization was 38.5% by 1 year. The rate of readmission for recurrent AF, atrial flutter, and/or repeat ablation was 21.7% by 1 year and 29.6% by 2 years. Periprocedural complications occurred in 1 of 20 patients undergoing AF ablation, and all-cause and arrhythmia-related rehospitalizations were common. Older age, female sex, prior AF hospitalizations, and recent hospital procedure experience were associated with a higher risk of complications and/or 30-day readmission after AF ablation.
AbstractList The purpose of this study was to estimate rates and identify predictors of inpatient complications and 30-day readmissions, as well as repeat hospitalization rates for arrhythmia recurrence following atrial fibrillation (AF) ablation. AF is the most common clinically significant arrhythmia and is associated with increased morbidity and mortality. Radiofrequency or cryotherapy ablation of AF is a relatively new treatment option, and data on post-procedural outcomes in large general populations are limited. Using data from the California State Inpatient Database, we identified all adult patients who underwent their first AF ablation from 2005 to 2008. We used multivariable logistic regression to identify predictors of complications and/or 30-day readmissions and Kaplan-Meier analyses to estimate rates of all-cause and arrhythmia readmissions. Among 4,156 patients who underwent an initial AF ablation, 5% had periprocedural complications, most commonly vascular, and 9% were readmitted within 30 days. Older age, female, prior AF hospitalizations, and less hospital experience with AF ablation were associated with higher adjusted risk of complications and/or 30-day readmissions. The rate of all-cause hospitalization was 38.5% by 1 year. The rate of readmission for recurrent AF, atrial flutter, and/or repeat ablation was 21.7% by 1 year and 29.6% by 2 years. Periprocedural complications occurred in 1 of 20 patients undergoing AF ablation, and all-cause and arrhythmia-related rehospitalizations were common. Older age, female sex, prior AF hospitalizations, and recent hospital procedure experience were associated with a higher risk of complications and/or 30-day readmission after AF ablation.
ObjectivesThe purpose of this study was to estimate rates and identify predictors of inpatient complications and 30-day readmissions, as well as repeat hospitalization rates for arrhythmia recurrence following atrial fibrillation (AF) ablation. BackgroundAF is the most common clinically significant arrhythmia and is associated with increased morbidity and mortality. Radiofrequency or cryotherapy ablation of AF is a relatively new treatment option, and data on post-procedural outcomes in large general populations are limited. MethodsUsing data from the California State Inpatient Database, we identified all adult patients who underwent their first AF ablation from 2005 to 2008. We used multivariable logistic regression to identify predictors of complications and/or 30-day readmissions and Kaplan-Meier analyses to estimate rates of all-cause and arrhythmia readmissions. ResultsAmong 4,156 patients who underwent an initial AF ablation, 5% had periprocedural complications, most commonly vascular, and 9% were readmitted within 30 days. Older age, female, prior AF hospitalizations, and less hospital experience with AF ablation were associated with higher adjusted risk of complications and/or 30-day readmissions. The rate of all-cause hospitalization was 38.5% by 1 year. The rate of readmission for recurrent AF, atrial flutter, and/or repeat ablation was 21.7% by 1 year and 29.6% by 2 years. ConclusionsPeriprocedural complications occurred in 1 of 20 patients undergoing AF ablation, and all-cause and arrhythmia-related rehospitalizations were common. Older age, female sex, prior AF hospitalizations, and recent hospital procedure experience were associated with a higher risk of complications and/or 30-day readmission after AF ablation.
Objectives The purpose of this study was to estimate rates and identify predictors of inpatient complications and 30-day readmissions, as well as repeat hospitalization rates for arrhythmia recurrence following atrial fibrillation (AF) ablation. Background AF is the most common clinically significant arrhythmia and is associated with increased morbidity and mortality. Radiofrequency or cryotherapy ablation of AF is a relatively new treatment option, and data on post-procedural outcomes in large general populations are limited. Methods Using data from the California State Inpatient Database, we identified all adult patients who underwent their first AF ablation from 2005 to 2008. We used multivariable logistic regression to identify predictors of complications and/or 30-day readmissions and Kaplan-Meier analyses to estimate rates of all-cause and arrhythmia readmissions. Results Among 4,156 patients who underwent an initial AF ablation, 5% had periprocedural complications, most commonly vascular, and 9% were readmitted within 30 days. Older age, female, prior AF hospitalizations, and less hospital experience with AF ablation were associated with higher adjusted risk of complications and/or 30-day readmissions. The rate of all-cause hospitalization was 38.5% by 1 year. The rate of readmission for recurrent AF, atrial flutter, and/or repeat ablation was 21.7% by 1 year and 29.6% by 2 years. Conclusions Periprocedural complications occurred in 1 of 20 patients undergoing AF ablation, and all-cause and arrhythmia-related rehospitalizations were common. Older age, female sex, prior AF hospitalizations, and recent hospital procedure experience were associated with a higher risk of complications and/or 30-day readmission after AF ablation.
The purpose of this study was to estimate rates and identify predictors of inpatient complications and 30-day readmissions, as well as repeat hospitalization rates for arrhythmia recurrence following atrial fibrillation (AF) ablation.OBJECTIVESThe purpose of this study was to estimate rates and identify predictors of inpatient complications and 30-day readmissions, as well as repeat hospitalization rates for arrhythmia recurrence following atrial fibrillation (AF) ablation.AF is the most common clinically significant arrhythmia and is associated with increased morbidity and mortality. Radiofrequency or cryotherapy ablation of AF is a relatively new treatment option, and data on post-procedural outcomes in large general populations are limited.BACKGROUNDAF is the most common clinically significant arrhythmia and is associated with increased morbidity and mortality. Radiofrequency or cryotherapy ablation of AF is a relatively new treatment option, and data on post-procedural outcomes in large general populations are limited.Using data from the California State Inpatient Database, we identified all adult patients who underwent their first AF ablation from 2005 to 2008. We used multivariable logistic regression to identify predictors of complications and/or 30-day readmissions and Kaplan-Meier analyses to estimate rates of all-cause and arrhythmia readmissions.METHODSUsing data from the California State Inpatient Database, we identified all adult patients who underwent their first AF ablation from 2005 to 2008. We used multivariable logistic regression to identify predictors of complications and/or 30-day readmissions and Kaplan-Meier analyses to estimate rates of all-cause and arrhythmia readmissions.Among 4,156 patients who underwent an initial AF ablation, 5% had periprocedural complications, most commonly vascular, and 9% were readmitted within 30 days. Older age, female, prior AF hospitalizations, and less hospital experience with AF ablation were associated with higher adjusted risk of complications and/or 30-day readmissions. The rate of all-cause hospitalization was 38.5% by 1 year. The rate of readmission for recurrent AF, atrial flutter, and/or repeat ablation was 21.7% by 1 year and 29.6% by 2 years.RESULTSAmong 4,156 patients who underwent an initial AF ablation, 5% had periprocedural complications, most commonly vascular, and 9% were readmitted within 30 days. Older age, female, prior AF hospitalizations, and less hospital experience with AF ablation were associated with higher adjusted risk of complications and/or 30-day readmissions. The rate of all-cause hospitalization was 38.5% by 1 year. The rate of readmission for recurrent AF, atrial flutter, and/or repeat ablation was 21.7% by 1 year and 29.6% by 2 years.Periprocedural complications occurred in 1 of 20 patients undergoing AF ablation, and all-cause and arrhythmia-related rehospitalizations were common. Older age, female sex, prior AF hospitalizations, and recent hospital procedure experience were associated with a higher risk of complications and/or 30-day readmission after AF ablation.CONCLUSIONSPeriprocedural complications occurred in 1 of 20 patients undergoing AF ablation, and all-cause and arrhythmia-related rehospitalizations were common. Older age, female sex, prior AF hospitalizations, and recent hospital procedure experience were associated with a higher risk of complications and/or 30-day readmission after AF ablation.
Author Hlatky, Mark A.
Shah, Rashmee U.
Freeman, James V.
Shilane, David
Wang, Paul J.
Go, Alan S.
AuthorAffiliation Stanford University School of Medicine, Stanford, California
Division of Research, Kaiser Permanente of Northern California, Oakland, California
University of California at San Francisco, San Francisco, California
AuthorAffiliation_xml – name: Stanford University School of Medicine, Stanford, California
– name: Division of Research, Kaiser Permanente of Northern California, Oakland, California
– name: University of California at San Francisco, San Francisco, California
Author_xml – sequence: 1
  givenname: Rashmee U.
  surname: Shah
  fullname: Shah, Rashmee U.
  email: rashmee.shah@cshs.org
  organization: Stanford University School of Medicine, Stanford, California
– sequence: 2
  givenname: James V.
  surname: Freeman
  fullname: Freeman, James V.
  organization: Stanford University School of Medicine, Stanford, California
– sequence: 3
  givenname: David
  surname: Shilane
  fullname: Shilane, David
  organization: Stanford University School of Medicine, Stanford, California
– sequence: 4
  givenname: Paul J.
  surname: Wang
  fullname: Wang, Paul J.
  organization: Stanford University School of Medicine, Stanford, California
– sequence: 5
  givenname: Alan S.
  surname: Go
  fullname: Go, Alan S.
  organization: Division of Research, Kaiser Permanente of Northern California, Oakland, California
– sequence: 6
  givenname: Mark A.
  surname: Hlatky
  fullname: Hlatky, Mark A.
  organization: Stanford University School of Medicine, Stanford, California
BackLink http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=25538424$$DView record in Pascal Francis
https://www.ncbi.nlm.nih.gov/pubmed/22222078$$D View this record in MEDLINE/PubMed
BookMark eNqFkl2L1DAUhoOsuB_6B7yQgog3zpi0SZqILAyDq8KC4gd4d0jTUydjJxmTzsL6602dGVcHXHvT9vR5356T856SIx88EvKQ0SmjTD5fTpfG2mlJGZtSNaVS3SEnTAg1qYSuj8gJrSsxYVTXx-Q0pSWlGWH6Hjkux4vW6oSk9zFYbDfR9MU8rNa9s2ZwwadnxQdchLR2g-ndj33N-DbX12iGYi_EVMy6AWMxN8MCx4dZ0__iiy7klyG67H3hmuj6bf0-uduZPuGD3f2MfL549Wn-ZnL57vXb-exyYqXiw6SURqGgdYNUlq2Sla057bpGV1YZ20iuqVKi4aLFkmNpaquk6DotWyWQUVWdkfOt73rTrLC16Ic8JqyjW5l4DcE4-PuLdwv4Gq5AVJwypbPB051BDN83mAZYuWQxj-ExbBJoxqXUmo_k4wNyGTbR5-mAidy-lpnM1KM_G_rdyX4dGXiyA0yypu-i8dalG06ISvGSZ05tORtDShE7sHlP49nmOVwPjMKYEFjCmBAYEwJUQV5_lpYH0r37raKXWxHmdV05jJCsQ5_37yLaAdrgbpefH8ht73xOWv8NrzHdHBWkEih8HHM7xpYxyiUtv2SDF_82-N_ffwLStv4g
CODEN JACCDI
CitedBy_id crossref_primary_10_1093_eurheartj_ehw210
crossref_primary_10_1161_CIRCEP_113_000768
crossref_primary_10_1111_jce_13494
crossref_primary_10_1007_s12170_013_0352_7
crossref_primary_10_1177_1089253212469840
crossref_primary_10_1016_j_jacep_2018_10_015
crossref_primary_10_1093_ejcts_ezw313
crossref_primary_10_1093_europace_euab198
crossref_primary_10_1093_europace_euad374
crossref_primary_10_1007_s15006_014_3580_y
crossref_primary_10_1016_j_hrthm_2014_03_013
crossref_primary_10_1161_CIRCULATIONAHA_113_002449
crossref_primary_10_1007_s00399_014_0343_5
crossref_primary_10_1016_j_amjcard_2016_01_040
crossref_primary_10_1111_jce_13123
crossref_primary_10_1111_jce_14454
crossref_primary_10_1097_HCO_0000000000000348
crossref_primary_10_1093_europace_euv266
crossref_primary_10_1161_JAHA_120_019599
crossref_primary_10_1093_europace_eus305
crossref_primary_10_1093_europace_eus304
crossref_primary_10_1177_2333392820961887
crossref_primary_10_14336_AD_2016_0211
crossref_primary_10_1161_CIRCEP_113_000760
crossref_primary_10_35336_VA_2021_E_3_16
crossref_primary_10_1016_j_hrthm_2023_02_016
crossref_primary_10_1016_j_ijcard_2015_05_145
crossref_primary_10_1093_europace_euab296
crossref_primary_10_1007_s40520_023_02514_8
crossref_primary_10_1016_j_crad_2013_08_018
crossref_primary_10_1016_j_amjcard_2017_11_034
crossref_primary_10_1161_CIRCEP_113_001281
crossref_primary_10_1002_clc_23335
crossref_primary_10_1007_s11239_015_1181_y
crossref_primary_10_1016_S0140_6736_16_31277_6
crossref_primary_10_1016_j_recesp_2020_10_022
crossref_primary_10_1111_jce_13142
crossref_primary_10_1007_s11936_014_0344_z
crossref_primary_10_1016_j_jacep_2015_12_005
crossref_primary_10_1093_europace_euad361
crossref_primary_10_1586_erc_12_62
crossref_primary_10_1016_j_ijcard_2014_11_105
crossref_primary_10_1111_jce_12731
crossref_primary_10_1093_europace_euw378
crossref_primary_10_3904_kjm_2021_96_4_264
crossref_primary_10_1016_j_ahj_2015_04_005
crossref_primary_10_1016_j_jacep_2015_04_016
crossref_primary_10_1253_circj_CJ_17_1213
crossref_primary_10_1093_europace_euaa415
crossref_primary_10_4070_kcj_2017_0327
crossref_primary_10_1093_ageing_afaa139
crossref_primary_10_1093_europace_euu002
crossref_primary_10_1007_s11886_016_0783_0
crossref_primary_10_1186_s13019_024_02710_1
crossref_primary_10_1111_jce_13051
crossref_primary_10_1093_europace_euy295
crossref_primary_10_1111_jce_12194
crossref_primary_10_1161_CIRCULATIONAHA_113_003862
crossref_primary_10_1007_s10840_012_9673_6
crossref_primary_10_1097_MLR_0000000000000274
crossref_primary_10_1111_jce_13042
crossref_primary_10_1161_CIRCULATIONAHA_116_022388
crossref_primary_10_4070_kcj_2022_0078
crossref_primary_10_1016_j_jacc_2023_03_418
crossref_primary_10_1161_CIRCULATIONAHA_116_022261
crossref_primary_10_36290_med_2016_035
crossref_primary_10_1161_CIRCEP_122_011365
crossref_primary_10_1161_CIRCEP_121_009790
crossref_primary_10_1136_heartjnl_2020_318282
crossref_primary_10_1016_j_hrcr_2016_09_008
crossref_primary_10_1002_clc_22812
crossref_primary_10_1161_CIRCEP_117_005579
crossref_primary_10_1111_jce_15495
crossref_primary_10_1111_pace_14309
crossref_primary_10_1007_s10439_016_1641_3
crossref_primary_10_1007_s10840_019_00697_7
crossref_primary_10_1016_j_jacep_2016_06_002
crossref_primary_10_3111_13696998_2014_911185
crossref_primary_10_1111_jce_12303
crossref_primary_10_1093_europace_euv229
crossref_primary_10_2217_fca_15_64
crossref_primary_10_1016_j_repce_2017_09_012
crossref_primary_10_1016_j_cger_2012_07_004
crossref_primary_10_1016_j_ahj_2015_05_018
crossref_primary_10_1016_j_amjcard_2017_07_057
crossref_primary_10_1016_j_jacc_2012_12_002
crossref_primary_10_1016_j_hrthm_2015_02_020
crossref_primary_10_1016_j_ijcard_2014_04_250
crossref_primary_10_1161_JAHA_115_001901
crossref_primary_10_1007_s12181_017_0146_0
crossref_primary_10_1111_pace_13905
crossref_primary_10_1007_s00380_021_01860_9
crossref_primary_10_1161_JAHA_118_009294
crossref_primary_10_1111_jce_14838
crossref_primary_10_1053_j_semtcvs_2012_04_007
crossref_primary_10_1016_j_jacep_2018_01_015
crossref_primary_10_1016_j_jacep_2016_02_005
crossref_primary_10_1002_prp2_880
crossref_primary_10_1007_s11886_013_0406_y
crossref_primary_10_1161_JAHA_120_016071
crossref_primary_10_1016_j_hrthm_2017_05_012
crossref_primary_10_1093_eurheartj_ehz085
crossref_primary_10_1093_europace_eux274
crossref_primary_10_1016_j_ultrasmedbio_2016_03_007
crossref_primary_10_1007_s00399_017_0486_2
crossref_primary_10_1016_j_amjcard_2012_10_013
crossref_primary_10_1016_j_jacep_2016_12_015
crossref_primary_10_1093_europace_eux034
crossref_primary_10_1111_jvim_17251
crossref_primary_10_1093_europace_eus378
crossref_primary_10_1016_j_jacc_2014_03_022
crossref_primary_10_5402_2012_376071
crossref_primary_10_7759_cureus_45082
crossref_primary_10_1161_CIRCEP_118_006754
crossref_primary_10_1093_europace_euy131
crossref_primary_10_1111_jce_14737
crossref_primary_10_1093_europace_eus393
crossref_primary_10_1111_jgs_14483
crossref_primary_10_1161_CIR_0000000000000041
crossref_primary_10_1111_jce_13081
crossref_primary_10_1111_jce_13083
crossref_primary_10_1093_eurheartj_ehy452
crossref_primary_10_1111_j_1540_8167_2012_02381_x
crossref_primary_10_1111_jce_13311
crossref_primary_10_1093_ejcts_ezt584
crossref_primary_10_1016_j_jacep_2017_05_005
crossref_primary_10_7759_cureus_40649
crossref_primary_10_1016_j_jacep_2022_02_014
crossref_primary_10_1097_JXX_0000000000000424
crossref_primary_10_1016_j_ahj_2015_10_015
crossref_primary_10_1016_j_jacep_2018_04_006
crossref_primary_10_1093_europace_eut004
crossref_primary_10_1161_CIRCEP_113_000597
crossref_primary_10_35336_VA_2020_3_9_24
crossref_primary_10_1093_eurheartj_ehw285
crossref_primary_10_1016_j_jacc_2013_09_026
crossref_primary_10_1136_heartjnl_2013_304592
crossref_primary_10_1093_eurheartj_ehaa612
crossref_primary_10_1161_CIRCULATIONAHA_112_109330
crossref_primary_10_1111_jce_12338
crossref_primary_10_1111_jce_14878
crossref_primary_10_1186_s12911_023_02347_5
crossref_primary_10_3390_jpm10030082
crossref_primary_10_1016_j_hrthm_2014_10_038
crossref_primary_10_1185_03007995_2014_922061
crossref_primary_10_1016_j_repc_2017_09_005
crossref_primary_10_1093_eurheartj_ehs253
crossref_primary_10_1016_j_hrthm_2014_08_021
crossref_primary_10_1089_jwh_2016_6282
crossref_primary_10_1007_s10840_022_01370_2
crossref_primary_10_1253_circrep_CR_21_0105
crossref_primary_10_1007_s10840_016_0141_6
crossref_primary_10_5124_jkma_2016_59_5_374
crossref_primary_10_1161_STROKEAHA_117_018501
crossref_primary_10_1007_s00399_017_0484_4
crossref_primary_10_1016_j_jtcvs_2012_07_065
crossref_primary_10_1016_j_ijcard_2012_12_088
crossref_primary_10_1161_JAHA_119_012595
crossref_primary_10_1016_j_joa_2012_03_003
crossref_primary_10_1177_201010581502400103
crossref_primary_10_1016_j_recesp_2012_11_001
crossref_primary_10_1586_14779072_2015_1011128
crossref_primary_10_1016_j_jacc_2013_09_004
crossref_primary_10_4236_wjcd_2016_65015
crossref_primary_10_1016_j_cjca_2014_08_001
crossref_primary_10_1016_j_amjcard_2019_10_048
crossref_primary_10_1111_jvim_16473
crossref_primary_10_1016_j_ipej_2017_10_001
crossref_primary_10_1007_s15006_012_0391_x
crossref_primary_10_1093_europace_euy213
crossref_primary_10_36469_9881
crossref_primary_10_1038_nrcardio_2018_20
crossref_primary_10_1016_j_crvasa_2012_12_002
crossref_primary_10_1111_pace_13041
crossref_primary_10_1002_joa3_12378
crossref_primary_10_1016_j_jacep_2020_02_009
crossref_primary_10_1016_j_amjcard_2012_11_026
crossref_primary_10_1111_pace_14013
crossref_primary_10_1007_s15027_012_0027_1
crossref_primary_10_5937_siks1404261L
crossref_primary_10_1111_jce_13471
crossref_primary_10_1111_jce_15893
crossref_primary_10_1016_j_hrthm_2017_04_042
crossref_primary_10_1007_s10840_018_0503_3
crossref_primary_10_1111_jce_13118
crossref_primary_10_2217_cer_2021_0170
crossref_primary_10_1016_j_jacep_2017_06_010
crossref_primary_10_1016_j_joa_2017_07_001
crossref_primary_10_1093_europace_euac068
crossref_primary_10_1161_CIRCEP_115_002890
crossref_primary_10_1016_j_hrthm_2014_07_017
crossref_primary_10_1111_pace_13971
crossref_primary_10_1186_s12872_020_01446_9
crossref_primary_10_1111_pace_12771
crossref_primary_10_1093_europace_euw295
crossref_primary_10_1007_s10840_019_00683_z
crossref_primary_10_1016_j_asjsur_2024_07_105
crossref_primary_10_1161_CIRCULATIONAHA_113_006197
crossref_primary_10_1016_j_ijcard_2022_06_019
crossref_primary_10_1111_j_1540_8167_2012_02318_x
crossref_primary_10_1016_j_amjcard_2017_03_006
crossref_primary_10_1007_s12170_019_0635_8
crossref_primary_10_1016_j_jacc_2011_08_070
Cites_doi 10.1016/S0002-8703(03)00079-6
10.1001/jama.291.2.195
10.1016/j.hrthm.2009.06.009
10.1001/jama.2010.748
10.1001/jama.285.18.2370
10.1016/j.jacc.2010.07.007
10.1161/01.CIR.0000157153.30978.67
10.1161/CIRCULATIONAHA.108.814996
10.1093/europace/eum120
10.1093/eurheartj/ehi583
10.1161/CIRCINTERVENTIONS.109.860494
10.1016/S0002-9149(97)00309-3
10.1001/archneur.59.12.1877
10.1056/NEJMsa0907130
10.1001/jama.293.21.2634
10.1016/j.jacc.2010.05.061
10.1161/CIRCULATIONAHA.105.595140
10.1136/bmj.39513.555150.BE
10.1016/j.jacc.2009.04.076
10.1016/j.hrthm.2007.06.016
10.1016/j.amjcard.2006.01.048
ContentType Journal Article
Copyright 2012 American College of Cardiology Foundation
American College of Cardiology Foundation
2015 INIST-CNRS
Copyright © 2012 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.
Copyright Elsevier Limited Jan 10, 2012
Copyright_xml – notice: 2012 American College of Cardiology Foundation
– notice: American College of Cardiology Foundation
– notice: 2015 INIST-CNRS
– notice: Copyright © 2012 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.
– notice: Copyright Elsevier Limited Jan 10, 2012
DBID 6I.
AAFTH
AAYXX
CITATION
IQODW
CGR
CUY
CVF
ECM
EIF
NPM
7T5
7TK
H94
K9.
NAPCQ
7X8
5PM
DOI 10.1016/j.jacc.2011.08.068
DatabaseName ScienceDirect Open Access Titles
Elsevier:ScienceDirect:Open Access
CrossRef
Pascal-Francis
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
Immunology Abstracts
Neurosciences Abstracts
AIDS and Cancer Research Abstracts
ProQuest Health & Medical Complete (Alumni)
Nursing & Allied Health Premium
MEDLINE - Academic
PubMed Central (Full Participant titles)
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
AIDS and Cancer Research Abstracts
ProQuest Health & Medical Complete (Alumni)
Nursing & Allied Health Premium
Immunology Abstracts
Neurosciences Abstracts
MEDLINE - Academic
DatabaseTitleList

AIDS and Cancer Research Abstracts

MEDLINE
MEDLINE - Academic
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1558-3597
EndPage 149
ExternalDocumentID PMC5340189
3243191911
22222078
25538424
10_1016_j_jacc_2011_08_068
S073510971104602X
1_s2_0_S073510971104602X
Genre Research Support, Non-U.S. Gov't
Journal Article
Research Support, N.I.H., Extramural
GeographicLocations California
United States--US
GeographicLocations_xml – name: California
– name: United States--US
GrantInformation_xml – fundername: American Heart Association
– fundername: National Institutes of Health
  grantid: 5UL1RR025744
– fundername: Stanford NIH/NCRR CTSA
  grantid: KL2RR025743
– fundername: NCRR NIH HHS
  grantid: UL1 RR025744
– fundername: NCRR NIH HHS
  grantid: 5UL1RR025744
– fundername: NCRR NIH HHS
  grantid: KL2RR025743
– fundername: NCRR NIH HHS
  grantid: KL2 RR025743
GroupedDBID ---
--K
--M
.1-
.FO
.~1
0R~
18M
1B1
1P~
1~.
1~5
2WC
4.4
457
4G.
53G
5GY
5RE
5VS
6PF
7-5
71M
8P~
AABNK
AABVL
AAEDT
AAEDW
AAIKJ
AAOAW
AAQFI
AAXUO
ABBQC
ABFNM
ABFRF
ABLJU
ABMAC
ABOCM
ABWVN
ABXDB
ACGFO
ACGFS
ACIUM
ACJTP
ACPRK
ACRPL
ACVFH
ADBBV
ADCNI
ADEZE
ADMUD
ADNMO
ADVLN
AEFWE
AEKER
AENEX
AEUPX
AEVXI
AEXQZ
AFPUW
AFRAH
AFRHN
AFTJW
AGCQF
AGHFR
AGYEJ
AHMBA
AIGII
AITUG
AJRQY
AKBMS
AKRWK
AKYEP
ALMA_UNASSIGNED_HOLDINGS
AMRAJ
BAWUL
BLXMC
CS3
DIK
DU5
E3Z
EBS
EFKBS
EJD
EO8
EO9
EP2
EP3
F5P
FDB
FEDTE
FNPLU
G-Q
GBLVA
GX1
H13
HVGLF
HZ~
IHE
IXB
J1W
K-O
KQ8
L7B
MO0
N9A
O-L
O9-
OA.
OAUVE
OK1
OL~
OZT
P-8
P-9
P2P
PC.
PQQKQ
PROAC
Q38
ROL
RPZ
SCC
SDF
SDG
SDP
SES
SSZ
TR2
UNMZH
UV1
W8F
WH7
WOQ
WOW
YYM
YZZ
Z5R
.55
.GJ
0SF
1CY
29L
3O-
3V.
6I.
7RV
AACTN
AAFTH
AAKUH
AALRI
AAQQT
AAQXK
AAYOK
ABMZM
ABVKL
AFCTW
AFETI
AFFNX
AJOXV
AMFUW
ASPBG
AVWKF
AZFZN
BENPR
BPHCQ
FGOYB
HX~
J5H
N4W
NCXOZ
QTD
R2-
RIG
SEW
T5K
X7M
XPP
YYP
ZGI
ZXP
AAIAV
ABJNI
EFLBG
LCYCR
NAHTW
ZA5
AAYWO
AAYXX
AGQPQ
CITATION
IQODW
CGR
CUY
CVF
ECM
EIF
NPM
7T5
7TK
H94
K9.
NAPCQ
7X8
~HD
5PM
ID FETCH-LOGICAL-c684t-26a8e507be062d863c740ffb93c8acb6490885b45de24e2a7c865ff96d85e1083
IEDL.DBID .~1
ISSN 0735-1097
1558-3597
IngestDate Thu Aug 21 13:59:47 EDT 2025
Sun Sep 28 08:25:14 EDT 2025
Sat Jul 26 03:03:47 EDT 2025
Mon Jul 21 06:04:49 EDT 2025
Mon Jul 21 09:14:35 EDT 2025
Thu Apr 24 23:01:42 EDT 2025
Tue Jul 01 03:41:20 EDT 2025
Fri Feb 23 02:28:22 EST 2024
Sun Feb 23 10:19:08 EST 2025
Tue Aug 26 16:32:50 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 2
Keywords atrial fibrillation
complication
ICD-9
outcomes
AF
pulmonary vein isolation
International Classification of Diseases-9th Edition
Arrhythmia
Rehospitalization
Heart disease
Atrial fibrillation
Catheter
Cardiovascular disease
Complication
Procedure
Circulatory system
Cardiology
Ablation
Excitability disorder
Language English
License http://www.elsevier.com/open-access/userlicense/1.0
https://www.elsevier.com/tdm/userlicense/1.0
CC BY 4.0
Copyright © 2012 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c684t-26a8e507be062d863c740ffb93c8acb6490885b45de24e2a7c865ff96d85e1083
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
Bruce D. Lindsay, MD, served as Guest Editor for this paper.
The first two authors contributed equally to this work.
OpenAccessLink https://www.sciencedirect.com/science/article/pii/S073510971104602X
PMID 22222078
PQID 1506296466
PQPubID 2031078
PageCount 7
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_5340189
proquest_miscellaneous_914669949
proquest_journals_1506296466
pubmed_primary_22222078
pascalfrancis_primary_25538424
crossref_citationtrail_10_1016_j_jacc_2011_08_068
crossref_primary_10_1016_j_jacc_2011_08_068
elsevier_sciencedirect_doi_10_1016_j_jacc_2011_08_068
elsevier_clinicalkeyesjournals_1_s2_0_S073510971104602X
elsevier_clinicalkey_doi_10_1016_j_jacc_2011_08_068
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2012-01-10
PublicationDateYYYYMMDD 2012-01-10
PublicationDate_xml – month: 01
  year: 2012
  text: 2012-01-10
  day: 10
PublicationDecade 2010
PublicationPlace New York, NY
PublicationPlace_xml – name: New York, NY
– name: United States
– name: New York
PublicationTitle Journal of the American College of Cardiology
PublicationTitleAlternate J Am Coll Cardiol
PublicationYear 2012
Publisher Elsevier Inc
Elsevier
Elsevier Limited
Publisher_xml – name: Elsevier Inc
– name: Elsevier
– name: Elsevier Limited
References Curtis, Schreiner, Wang (bib8) 2009; 54
Ahmed, Piper, Malenka (bib14) 2009; 2
Argulian, Patel, Abramson (bib16) 2006; 98
Miyasaka, Barnes, Gersh (bib2) 2006; 114
Bueno, Ross, Wang (bib11) 2010; 303
Feasby, Quan, Ghali (bib19) 2002; 59
Wazni, Marrouche, Martin (bib12) 2005; 293
Juergens, Semsarian, Keech, Beller, Harris (bib18) 1997; 80
Bertaglia, Zoppo, Tondo (bib9) 2007; 4
Peterson, Coombs, DeLong, Haan, Ferguson (bib21) 2004; 291
Ellis, Culler, Simon, Reynolds (bib6) 2009; 6
Calkins, Brugada, Packer (bib10) 2007; 9
Weerasooriya, Khairy, Litalien (bib5) 2011; 57
Freeman, Wang, Curtis, Heidenreich, Hlatky (bib20) 2010; 56
(bib7) 2005–2009
Piper, Malenka, Ryan (bib15) 2003; 145
Cheng, Morrow, Sloan, Antman, Sabatine (bib17) 2009; 119
Ross, Normand, Wang (bib22) 2010; 362
Go, Hylek, Phillips (bib1) 2001; 285
Lubitz, Fischer, Fuster (bib3) 2008; 336
Cappato, Calkins, Chen (bib4) 2005; 111
Stabile, Bertaglia, Senatore (bib13) 2006; 27
(10.1016/j.jacc.2011.08.068_bib7) 2005
Go (10.1016/j.jacc.2011.08.068_bib1) 2001; 285
Feasby (10.1016/j.jacc.2011.08.068_bib19) 2002; 59
Ahmed (10.1016/j.jacc.2011.08.068_bib14) 2009; 2
Calkins (10.1016/j.jacc.2011.08.068_bib10) 2007; 9
Cheng (10.1016/j.jacc.2011.08.068_bib17) 2009; 119
Juergens (10.1016/j.jacc.2011.08.068_bib18) 1997; 80
Bertaglia (10.1016/j.jacc.2011.08.068_bib9) 2007; 4
Argulian (10.1016/j.jacc.2011.08.068_bib16) 2006; 98
Weerasooriya (10.1016/j.jacc.2011.08.068_bib5) 2011; 57
Ellis (10.1016/j.jacc.2011.08.068_bib6) 2009; 6
Curtis (10.1016/j.jacc.2011.08.068_bib8) 2009; 54
Stabile (10.1016/j.jacc.2011.08.068_bib13) 2006; 27
Piper (10.1016/j.jacc.2011.08.068_bib15) 2003; 145
Bueno (10.1016/j.jacc.2011.08.068_bib11) 2010; 303
Cappato (10.1016/j.jacc.2011.08.068_bib4) 2005; 111
Ross (10.1016/j.jacc.2011.08.068_bib22) 2010; 362
Miyasaka (10.1016/j.jacc.2011.08.068_bib2) 2006; 114
Wazni (10.1016/j.jacc.2011.08.068_bib12) 2005; 293
Freeman (10.1016/j.jacc.2011.08.068_bib20) 2010; 56
Peterson (10.1016/j.jacc.2011.08.068_bib21) 2004; 291
Lubitz (10.1016/j.jacc.2011.08.068_bib3) 2008; 336
15723973 - Circulation. 2005 Mar 8;111(9):1100-5
20335587 - N Engl J Med. 2010 Mar 25;362(12):1110-8
11343485 - JAMA. 2001 May 9;285(18):2370-5
21211687 - J Am Coll Cardiol. 2011 Jan 11;57(2):160-6
J Am Coll Cardiol. 2012 Apr 17;59(16):1492
20863954 - J Am Coll Cardiol. 2010 Sep 28;56(14):1133-9
15928285 - JAMA. 2005 Jun 1;293(21):2634-40
19716081 - Heart Rhythm. 2009 Sep;6(9):1267-73
12796758 - Am Heart J. 2003 Jun;145(6):1022-9
17599941 - Europace. 2007 Jun;9(6):335-79
17905330 - Heart Rhythm. 2007 Oct;4(10):1265-71
9230150 - Am J Cardiol. 1997 Jul 15;80(2):150-4
22222079 - J Am Coll Cardiol. 2012 Jan 10;59(2):150-2
18403546 - BMJ. 2008 Apr 12;336(7648):819-26
19237657 - Circulation. 2009 Mar 10;119(9):1195-202
16818816 - Circulation. 2006 Jul 11;114(2):119-25
20031752 - Circ Cardiovasc Interv. 2009 Oct;2(5):423-9
20516414 - JAMA. 2010 Jun 2;303(21):2141-7
14722145 - JAMA. 2004 Jan 14;291(2):195-201
16214831 - Eur Heart J. 2006 Jan;27(2):216-21
19712799 - J Am Coll Cardiol. 2009 Sep 1;54(10):903-7
12470174 - Arch Neurol. 2002 Dec;59(12):1877-81
16784919 - Am J Cardiol. 2006 Jul 1;98(1):48-53
References_xml – volume: 303
  start-page: 2141
  year: 2010
  end-page: 2147
  ident: bib11
  article-title: Trends in length of stay and short-term outcomes among Medicare patients hospitalized for heart failure, 1993–2006
  publication-title: JAMA
– volume: 98
  start-page: 48
  year: 2006
  end-page: 53
  ident: bib16
  article-title: Gender differences in short-term cardiovascular outcomes after percutaneous coronary interventions
  publication-title: Am J Cardiol
– volume: 80
  start-page: 150
  year: 1997
  end-page: 154
  ident: bib18
  article-title: Hemorrhagic complications of intravenous heparin use
  publication-title: Am J Cardiol
– volume: 57
  start-page: 160
  year: 2011
  end-page: 166
  ident: bib5
  article-title: Catheter ablation for atrial fibrillation: are results maintained at 5 years of follow-up?
  publication-title: J Am Coll Cardiol
– volume: 56
  start-page: 1133
  year: 2010
  end-page: 1139
  ident: bib20
  article-title: The relation between hospital procedure volume and complications of cardioverter-defibrillator implantation from the implantable cardioverter-defibrillator registry
  publication-title: J Am Coll Cardiol
– volume: 6
  start-page: 1267
  year: 2009
  end-page: 1273
  ident: bib6
  article-title: Trends in utilization and complications of catheter ablation for atrial fibrillation in Medicare beneficiaries
  publication-title: Heart Rhythm
– volume: 4
  start-page: 1265
  year: 2007
  end-page: 1271
  ident: bib9
  article-title: Early complications of pulmonary vein catheter ablation for atrial fibrillation: a multicenter prospective registry on procedural safety
  publication-title: Heart Rhythm
– volume: 362
  start-page: 1110
  year: 2010
  end-page: 1118
  ident: bib22
  article-title: Hospital volume and 30-day mortality for three common medical conditions
  publication-title: N Engl J Med
– volume: 59
  start-page: 1877
  year: 2002
  end-page: 1881
  ident: bib19
  article-title: Hospital and surgeon determinants of carotid endarterectomy outcomes
  publication-title: Arch Neurol
– volume: 2
  start-page: 423
  year: 2009
  end-page: 429
  ident: bib14
  article-title: Significantly improved vascular complications among women undergoing percutaneous coronary intervention: a report from the Northern New England Percutaneous Coronary Intervention Registry
  publication-title: Circ Cardiovasc Interv
– year: 2005–2009
  ident: bib7
  article-title: HCUP State Inpatient Databases (SID)
– volume: 291
  start-page: 195
  year: 2004
  end-page: 201
  ident: bib21
  article-title: Procedural volume as a marker of quality for CABG surgery
  publication-title: JAMA
– volume: 145
  start-page: 1022
  year: 2003
  end-page: 1029
  ident: bib15
  article-title: Predicting vascular complications in percutaneous coronary interventions
  publication-title: Am Heart J
– volume: 114
  start-page: 119
  year: 2006
  end-page: 125
  ident: bib2
  article-title: Secular trends in incidence of atrial fibrillation in Olmsted County, Minnesota, 1980 to 2000, and implications on the projections for future prevalence
  publication-title: Circulation
– volume: 119
  start-page: 1195
  year: 2009
  end-page: 1202
  ident: bib17
  article-title: Predictors of initial nontherapeutic anticoagulation with unfractionated heparin in ST-segment elevation myocardial infarction
  publication-title: Circulation
– volume: 111
  start-page: 1100
  year: 2005
  end-page: 1105
  ident: bib4
  article-title: Worldwide survey on the methods, efficacy, and safety of catheter ablation for human atrial fibrillation
  publication-title: Circulation
– volume: 336
  start-page: 819
  year: 2008
  end-page: 826
  ident: bib3
  article-title: Catheter ablation for atrial fibrillation
  publication-title: BMJ
– volume: 9
  start-page: 335
  year: 2007
  end-page: 379
  ident: bib10
  article-title: HRS/EHRA/ECAS expert consensus statement on catheter and surgical ablation of atrial fibrillation: recommendations for personnel, policy, procedures and follow-up
  publication-title: Europace
– volume: 293
  start-page: 2634
  year: 2005
  end-page: 2640
  ident: bib12
  article-title: Radiofrequency ablation vs antiarrhythmic drugs as first-line treatment of symptomatic atrial fibrillation: a randomized trial
  publication-title: JAMA
– volume: 27
  start-page: 216
  year: 2006
  end-page: 221
  ident: bib13
  article-title: Catheter ablation treatment in patients with drug-refractory atrial fibrillation: a prospective, multi-centre, randomized, controlled study (Catheter Ablation for the Cure of Atrial Fibrillation study)
  publication-title: Eur Heart J
– volume: 54
  start-page: 903
  year: 2009
  end-page: 907
  ident: bib8
  article-title: All-cause readmission and repeat revascularization after percutaneous coronary intervention in a cohort of Medicare patients
  publication-title: J Am Coll Cardiol
– volume: 285
  start-page: 2370
  year: 2001
  end-page: 2375
  ident: bib1
  article-title: Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the Anticoagulation and Risk Factors in Atrial Fibrillation (ATRIA) study
  publication-title: JAMA
– volume: 145
  start-page: 1022
  year: 2003
  ident: 10.1016/j.jacc.2011.08.068_bib15
  article-title: Predicting vascular complications in percutaneous coronary interventions
  publication-title: Am Heart J
  doi: 10.1016/S0002-8703(03)00079-6
– volume: 291
  start-page: 195
  year: 2004
  ident: 10.1016/j.jacc.2011.08.068_bib21
  article-title: Procedural volume as a marker of quality for CABG surgery
  publication-title: JAMA
  doi: 10.1001/jama.291.2.195
– volume: 6
  start-page: 1267
  year: 2009
  ident: 10.1016/j.jacc.2011.08.068_bib6
  article-title: Trends in utilization and complications of catheter ablation for atrial fibrillation in Medicare beneficiaries
  publication-title: Heart Rhythm
  doi: 10.1016/j.hrthm.2009.06.009
– volume: 303
  start-page: 2141
  year: 2010
  ident: 10.1016/j.jacc.2011.08.068_bib11
  article-title: Trends in length of stay and short-term outcomes among Medicare patients hospitalized for heart failure, 1993–2006
  publication-title: JAMA
  doi: 10.1001/jama.2010.748
– volume: 285
  start-page: 2370
  year: 2001
  ident: 10.1016/j.jacc.2011.08.068_bib1
  article-title: Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the Anticoagulation and Risk Factors in Atrial Fibrillation (ATRIA) study
  publication-title: JAMA
  doi: 10.1001/jama.285.18.2370
– volume: 56
  start-page: 1133
  year: 2010
  ident: 10.1016/j.jacc.2011.08.068_bib20
  article-title: The relation between hospital procedure volume and complications of cardioverter-defibrillator implantation from the implantable cardioverter-defibrillator registry
  publication-title: J Am Coll Cardiol
  doi: 10.1016/j.jacc.2010.07.007
– volume: 111
  start-page: 1100
  year: 2005
  ident: 10.1016/j.jacc.2011.08.068_bib4
  article-title: Worldwide survey on the methods, efficacy, and safety of catheter ablation for human atrial fibrillation
  publication-title: Circulation
  doi: 10.1161/01.CIR.0000157153.30978.67
– volume: 119
  start-page: 1195
  year: 2009
  ident: 10.1016/j.jacc.2011.08.068_bib17
  article-title: Predictors of initial nontherapeutic anticoagulation with unfractionated heparin in ST-segment elevation myocardial infarction
  publication-title: Circulation
  doi: 10.1161/CIRCULATIONAHA.108.814996
– year: 2005
  ident: 10.1016/j.jacc.2011.08.068_bib7
– volume: 9
  start-page: 335
  year: 2007
  ident: 10.1016/j.jacc.2011.08.068_bib10
  article-title: HRS/EHRA/ECAS expert consensus statement on catheter and surgical ablation of atrial fibrillation: recommendations for personnel, policy, procedures and follow-up
  publication-title: Europace
  doi: 10.1093/europace/eum120
– volume: 27
  start-page: 216
  year: 2006
  ident: 10.1016/j.jacc.2011.08.068_bib13
  article-title: Catheter ablation treatment in patients with drug-refractory atrial fibrillation: a prospective, multi-centre, randomized, controlled study (Catheter Ablation for the Cure of Atrial Fibrillation study)
  publication-title: Eur Heart J
  doi: 10.1093/eurheartj/ehi583
– volume: 2
  start-page: 423
  year: 2009
  ident: 10.1016/j.jacc.2011.08.068_bib14
  article-title: Significantly improved vascular complications among women undergoing percutaneous coronary intervention: a report from the Northern New England Percutaneous Coronary Intervention Registry
  publication-title: Circ Cardiovasc Interv
  doi: 10.1161/CIRCINTERVENTIONS.109.860494
– volume: 80
  start-page: 150
  year: 1997
  ident: 10.1016/j.jacc.2011.08.068_bib18
  article-title: Hemorrhagic complications of intravenous heparin use
  publication-title: Am J Cardiol
  doi: 10.1016/S0002-9149(97)00309-3
– volume: 59
  start-page: 1877
  year: 2002
  ident: 10.1016/j.jacc.2011.08.068_bib19
  article-title: Hospital and surgeon determinants of carotid endarterectomy outcomes
  publication-title: Arch Neurol
  doi: 10.1001/archneur.59.12.1877
– volume: 362
  start-page: 1110
  year: 2010
  ident: 10.1016/j.jacc.2011.08.068_bib22
  article-title: Hospital volume and 30-day mortality for three common medical conditions
  publication-title: N Engl J Med
  doi: 10.1056/NEJMsa0907130
– volume: 293
  start-page: 2634
  year: 2005
  ident: 10.1016/j.jacc.2011.08.068_bib12
  article-title: Radiofrequency ablation vs antiarrhythmic drugs as first-line treatment of symptomatic atrial fibrillation: a randomized trial
  publication-title: JAMA
  doi: 10.1001/jama.293.21.2634
– volume: 57
  start-page: 160
  year: 2011
  ident: 10.1016/j.jacc.2011.08.068_bib5
  article-title: Catheter ablation for atrial fibrillation: are results maintained at 5 years of follow-up?
  publication-title: J Am Coll Cardiol
  doi: 10.1016/j.jacc.2010.05.061
– volume: 114
  start-page: 119
  year: 2006
  ident: 10.1016/j.jacc.2011.08.068_bib2
  article-title: Secular trends in incidence of atrial fibrillation in Olmsted County, Minnesota, 1980 to 2000, and implications on the projections for future prevalence
  publication-title: Circulation
  doi: 10.1161/CIRCULATIONAHA.105.595140
– volume: 336
  start-page: 819
  year: 2008
  ident: 10.1016/j.jacc.2011.08.068_bib3
  article-title: Catheter ablation for atrial fibrillation
  publication-title: BMJ
  doi: 10.1136/bmj.39513.555150.BE
– volume: 54
  start-page: 903
  year: 2009
  ident: 10.1016/j.jacc.2011.08.068_bib8
  article-title: All-cause readmission and repeat revascularization after percutaneous coronary intervention in a cohort of Medicare patients
  publication-title: J Am Coll Cardiol
  doi: 10.1016/j.jacc.2009.04.076
– volume: 4
  start-page: 1265
  year: 2007
  ident: 10.1016/j.jacc.2011.08.068_bib9
  article-title: Early complications of pulmonary vein catheter ablation for atrial fibrillation: a multicenter prospective registry on procedural safety
  publication-title: Heart Rhythm
  doi: 10.1016/j.hrthm.2007.06.016
– volume: 98
  start-page: 48
  year: 2006
  ident: 10.1016/j.jacc.2011.08.068_bib16
  article-title: Gender differences in short-term cardiovascular outcomes after percutaneous coronary interventions
  publication-title: Am J Cardiol
  doi: 10.1016/j.amjcard.2006.01.048
– reference: 20031752 - Circ Cardiovasc Interv. 2009 Oct;2(5):423-9
– reference: 11343485 - JAMA. 2001 May 9;285(18):2370-5
– reference: 21211687 - J Am Coll Cardiol. 2011 Jan 11;57(2):160-6
– reference: 15928285 - JAMA. 2005 Jun 1;293(21):2634-40
– reference: 19237657 - Circulation. 2009 Mar 10;119(9):1195-202
– reference: 18403546 - BMJ. 2008 Apr 12;336(7648):819-26
– reference: 16818816 - Circulation. 2006 Jul 11;114(2):119-25
– reference: 19716081 - Heart Rhythm. 2009 Sep;6(9):1267-73
– reference: 19712799 - J Am Coll Cardiol. 2009 Sep 1;54(10):903-7
– reference: 22222079 - J Am Coll Cardiol. 2012 Jan 10;59(2):150-2
– reference: 20335587 - N Engl J Med. 2010 Mar 25;362(12):1110-8
– reference: 16784919 - Am J Cardiol. 2006 Jul 1;98(1):48-53
– reference: 12470174 - Arch Neurol. 2002 Dec;59(12):1877-81
– reference: 16214831 - Eur Heart J. 2006 Jan;27(2):216-21
– reference: 17905330 - Heart Rhythm. 2007 Oct;4(10):1265-71
– reference: 9230150 - Am J Cardiol. 1997 Jul 15;80(2):150-4
– reference: 15723973 - Circulation. 2005 Mar 8;111(9):1100-5
– reference: 17599941 - Europace. 2007 Jun;9(6):335-79
– reference: 20863954 - J Am Coll Cardiol. 2010 Sep 28;56(14):1133-9
– reference: - J Am Coll Cardiol. 2012 Apr 17;59(16):1492
– reference: 12796758 - Am Heart J. 2003 Jun;145(6):1022-9
– reference: 14722145 - JAMA. 2004 Jan 14;291(2):195-201
– reference: 20516414 - JAMA. 2010 Jun 2;303(21):2141-7
SSID ssj0006819
Score 2.5034678
Snippet The purpose of this study was to estimate rates and identify predictors of inpatient complications and 30-day readmissions, as well as repeat hospitalization...
ObjectivesThe purpose of this study was to estimate rates and identify predictors of inpatient complications and 30-day readmissions, as well as repeat...
Objectives The purpose of this study was to estimate rates and identify predictors of inpatient complications and 30-day readmissions, as well as repeat...
SourceID pubmedcentral
proquest
pubmed
pascalfrancis
crossref
elsevier
SourceType Open Access Repository
Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 143
SubjectTerms Adult
Aged
Aged, 80 and over
atrial fibrillation
Atrial Fibrillation - surgery
Biological and medical sciences
California
Cardiac arrhythmia
Cardiac dysrhythmias
Cardiology
Cardiology. Vascular system
Cardiovascular
Cardiovascular disease
Catheter Ablation - adverse effects
Catheters
complication
Female
Heart
Hospitalization
Hospitals
Humans
Male
Medical sciences
Middle Aged
outcomes
Patient Readmission - statistics & numerical data
pulmonary vein isolation
Reoperation - statistics & numerical data
Treatment Outcome
Title Procedural Complications, Rehospitalizations, and Repeat Procedures After Catheter Ablation for Atrial Fibrillation
URI https://www.clinicalkey.com/#!/content/1-s2.0-S073510971104602X
https://www.clinicalkey.es/playcontent/1-s2.0-S073510971104602X
https://dx.doi.org/10.1016/j.jacc.2011.08.068
https://www.ncbi.nlm.nih.gov/pubmed/22222078
https://www.proquest.com/docview/1506296466
https://www.proquest.com/docview/914669949
https://pubmed.ncbi.nlm.nih.gov/PMC5340189
Volume 59
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3db9MwELemPSAkhPgmMCY_8MZCE8d27cdSUQ2k8QBM6pvlr2idpqwi3St_O3eJk7YwhkQfqtbxpbXvfL7Iv7sfIW-9LXmskdCkYCHnpZW51XWZR6ZtqINykmO-89kXeXrOPy_F8oDMh1wYhFUm39_79M5bp5ZJms3JerWafAPjFHh-WuIxZcGWmMHOp2jr739uYR5SdeQe2DnH3ilxpsd4XVrvd8p4qr9tTg_WtoUpq3uui9uC0d8xlTub1OIReZiiSzrrB_CYHMTmCbl3ls7Pn5K2ywsIWGqDznfB5Cf0a7xIFCJDZuYJtU2A9jW4azoIxpbOkFacdqmD-GHmejgdhfCXzjoWELrARIKrvv0ZOV98_D4_zRPtQu6l4pucSasihIkuFpIFJSs_5UVdO115ZT0oD6FRwnERIuOR2alXUtS1lkGJWEJI95wcNtdNfEmodcyBCwmldg5Uo6ysXNAerEaWATSSkXKYb-NTTXKkxrgyA_js0qCODOrIIF-mVBl5N8qs-4ocd_auBjWaIdcUvKOBDeNOqeltUrFNC7w1pWmZKcwfRpgRMUru2fE_f_F4z8bGocEjX6U44xk5GozObP-FABVpyaXMCB0vg4PAUx_bxOub1mjYC6XWXGfkRW-i23vjC2JEGO6e8Y4dsPb4_pVmddHVIBcVPJgr_eo_h_ua3IdvCAqCRXlEDjc_buIbiO427rhbvvD-afnhFxGrUGw
linkProvider Elsevier
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3db9MwELfGkAAJIb4JjOEH3li0xHFc-7FUVB2se4BN6pvlr2idpqwi3f_PXeJkLYwh0afK9jW17-fzRb67HyEfncl5qJDQJGM-5bkRqVFVngamjK-8tIJjvvP8RMzO-NdFudghkz4XBsMqo-3vbHprrWPLYVzNw9VyefgDwFni_WmO15QZW9wj98EbyBDaR4vPgzkWsmX3wNEpDo-ZM12Q14VxbqOOp_zb6fR4ZRpYs6oju7jNG_09qHLjlJo-JU-ie0nH3QyekZ1QPycP5vEC_QVp2sQAj7U26GQzmvyAfg_nkUOkT808oKb20L4Ce017wdDQMfKK0zZ3EL-MbRdPR8H_peOWBoROMZPgsmt_Sc6mX04nszTyLqROSL5OmTAygJ9oQyaYl6JwI55VlVWFk8aB9jA2qrS89IHxwMzISVFWlRJeliEHn-4V2a2v6vCGUGOZBRvic2UtHxXSiMJ65QA2IvegkYTk_XprF4uSIzfGpe6jzy406kijjjQSZgqZkE-DzKoryXHn6KJXo-6TTcE8ajgx7pQa3SYVmrjDG53rhulM_4HChJSD5BaQ__nE_S2MDVODd75CcsYTsteDTt_8ixJUpAQXIiF06AYLgdc-pg5X141WcBgKpbhKyOsOoje_jR9wEmG6W-AdBmDx8e2eenneFiEvC3gzl-rtf073A3k4O50f6-Ojk2_vyCPowQgh2KB7ZHf98zq8B1dvbffbrfwLGplSlQ
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Procedural+Complications%2C+Rehospitalizations%2C+and+Repeat+Procedures+After+Catheter+Ablation+for+Atrial+Fibrillation&rft.jtitle=Journal+of+the+American+College+of+Cardiology&rft.au=Shah%2C+Rashmee+U.&rft.au=Freeman%2C+James+V.&rft.au=Shilane%2C+David&rft.au=Wang%2C+Paul+J.&rft.date=2012-01-10&rft.pub=Elsevier+Inc&rft.issn=0735-1097&rft.volume=59&rft.issue=2&rft.spage=143&rft.epage=149&rft_id=info:doi/10.1016%2Fj.jacc.2011.08.068&rft.externalDocID=S073510971104602X
thumbnail_m http://utb.summon.serialssolutions.com/2.0.0/image/custom?url=https%3A%2F%2Fcdn.clinicalkey.com%2Fck-thumbnails%2F07351097%2FS0735109711X00505%2Fcov150h.gif